Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: vancomycin attending: chief complaint: tracheobronchomalacia with airway occlusion from granulation tissue. major surgical or invasive procedure: 1. flexible and rigid bronchoscopy. 2. foreign body (silicone stent) removal. 3. excision of granulation tissue with electrocautery. 4. stent placement in the left mainstem and trachea. rigid and flexible bronchoscopy, foreign body (stent) removal, and tracheostomy revision with replacement of tracheal tube. history of present illness: 23 year-old male with history of static encephalitis at 2 mo old, chronic seizure disease, and trachomalacia s/p y-stent/trach at , discharged on after prolonged hospitalization for pseudomonas pneumonia and tracheomalacia requiring trach/g-tube placement. approximately one month following hospitalization, the patient had increased suctioning requirements and intermittent fevers and was admitted to , where he was found to have recurrent left lower lobe pseudomonal and mrsa pneumonia and started on meropenem and gentamicin. he was also found to have granulation tissue and mucuous in his trach tube and was transferred to the for stent placement and trach change. past medical history: pmh: 1.diphtheria static encephalitis at 2mo old 2.infantile spasms progressing to refractory seizure d/o seizure history, as documented by neurology: h/o chronic seizure d/o which started as infantile spasms and progressed to refractory seizures. per father, at baseline, patient has spastic movements of his arms and legs. he has about 3 seizures per day, which consist of his "arms and mouth stiffening," and twitching movements of his mouth. during his hospitalization , he was found to have a dilantin level of 37.3 and phenobarbital level of 23.5; his dilantin was held until levels became non-toxic and the dose was then decreased to 100 mg po qam and 125 mg po qpm. his dilantin level prior to transfer was 14.6. 3.s/p vns in social history: mother - healthy father - seizure disorder - 0-3 seizure/day. his seizures are manifest as generalized tonic events with arm and leg stffening and facial grimacing movements. these episodes typically last 1-2 minutes and self resolve. the family uses diastat prn seizure> 5 minutes. father is not sure if patient has ever had an episode of status epilepticus or required icu stay for his seizures. family history: non-contributory physical exam: general: lying in bed, non-communicative heent: large ears and no other dysmorphic features cv: rrr on tele resp: copius ua secretions transmitted ab: gtube, s, nd ext: contractures in le, flaccid ue and mae spont neuro: mse: awake, non-verbal, does not respond to commands. cn's: perrl. does not track movement but blinks to threat and light. he averts eyes to light. his tongue appear ml. gags with suctioning. bifacial weakness. pertinent results: wbc-6.1 rbc-3.73* hgb-11.2* hct-32.9 plt ct-342 wbc-11.6*# rbc-3.87* hgb-11.8* hct-33.0 plt ct-353 wbc-4.2 rbc-3.28* hgb-10.0* hct-28.8* wbc-6.1 rbc-3.90* hgb-11.8* hct-34.8 plt ct-291 glucose-95 urean-7 creat-0.5 na-136 k-4.0 cl-101 hco3-29 glucose-97 urean-13 creat-0.5 na-138 k-3.9 cl-104 hco3-25 02:41am blood calcium-9.3 phos-4.1 mg-2.1 02:29am blood phenyto-15.0 phenoba-18.5 phenyto-7.6* phenoba-19.7 phenyto-6.0* phenyto-8.4* phenyto-8.4* phenyfr-0.9* %phenyf-11 phenyto-11.8 chest x-ray a roughly 6 cm long tracheostomy cannula ends at the level of the thoracic inlet at the upper margin of a tracheal stent which is seen to continue into the left main bronchus. a right bronchial component is not clearly identified, nor is the connection between the trachea and left bronchial components. lung volumes are generally low and pulmonary vasculature is congested. opacification at the base of the left lung could be atelectasis or pneumonia. heart size is top normal. tip of the left pic catheter projects over the mid svc. a left axillary power pack may be the source of a filamentous lead heading inferiorly, but the connection is not clear. pleural effusion, if any, is small, on the left. there is no pneumothorax. chest (portable ap) 1:11 pm findings: comparison with study of , allowing for differences in obliquity of the patient, there is little change. the tracheal tube tip lies about 2.5 cm above the carina. no evidence of focal pneumonia. brief hospital course: admitted on and underwent flexible and rigid bronchoscopy, foreign body (silicone stent) removal, excision of granulation tissue with electrocautery, 12x4 ultraflex stent placement in left mainstem, 16x4 ultraflex stent in trachea, and portex #6 uncuffed tracheostomy tube placed. the patient tolerated the procedure well with no complications. he returned to ticu on humified trach mask. antibiotics (gentamicin, meropenem) were continued for pseudomonal pneumonal coverage. a bronchoscopy was obtained by interventional pulmonology on , which revealed patient tracheal and left mainstem stents. neurology was consulted to evaluate and provide management recommendations for the patient's seizure disorder. he continued on phenytoin, topamax, clonazepam, and phenobarbital, with drug levels monitored daily. for nutrition, he was maintained on probalance 65cc/hr x24 hr(1872 kcals, 84g protein). repeat bronchoscopy was done on , found stent in appropriate position and patent airways. in the evening of , the patient was found to have increased secretions and became tachypneic, hypertensive, and tachycardic. oxygen sats dropped to 80%. respiratory therapy attempted to bag ventilate, yet had difficulty. the patient was transferred to the sicu where he was bronched at the bedside. the uncuffed portex #6 trach was changed to a portex #6 cuffed tube. the patient was placed on a propofol drip and ventilator, with improvement in oxygen saturation. fentanyl and lorazepam were administered for breakthrough agitation, with good response. repeat bronchoscopy obtained on which revealed distal stent migration. it was pulled back to the proximal trachea and redilated to 15-16mm with a balloon. on the patient underwent a rigid and flexible bronchoscopy with removal of the tracheal stent and tracheostomy revision. a 7 cuffed tracheal tube was placed, with lms stent in place. the patient tolerated the procedure well. multiple attempts were made to wean the patient off the ventilator. on the patient was successfully weaned to trach collar, which he has since tolerated. he continued to do well over the weekend. his abdomen became distended, the tube feeds were held, kub obtained which showed mild gastric diltation which resolved. his tube-feeds were restarted which he tolerated well. on discharge, the patient will return to house on previously prescribed seizure medications. there is no indication for antibiotics at this time. medications on admission: meds on transfer: phenobarbital 60 mg po bid phenytoin 100 mg po qam 125 mg po qpm topiramate 225 mg po qam 250 mg po qpm clonazepam 2 mg po qam 3 mg po qpm lorazepam 1 mg iv q 4hr prn agitation 2 mg iv q4hr prn seizure activity meropenem mg iv q8hr discharge medications: 1. heparin (porcine) 5,000 unit/ml solution : one (1) injection tid (3 times a day). 2. mupirocin calcium 2 % cream : one (1) appl topical tid (3 times a day). 3. albuterol-ipratropium 103-18 mcg/actuation aerosol : puffs inhalation q6h (every 6 hours). 4. clonazepam 1 mg tablet : two (2) tablet po qam (once a day (in the morning)). 5. clonazepam 1 mg tablet : three (3) tablet po qpm (once a day (in the evening)). 6. phenobarbital 30 mg tablet : two (2) tablet po bid (2 times a day). 7. phenytoin 50 mg tablet, chewable : two (2) tablet, chewable po qam (once a day (in the morning)). 8. phenytoin 50 mg tablet, chewable : 2.5 tablet, chewables po qpm (once a day (in the evening)). 9. lansoprazole 30 mg tablet,rapid dissolve, dr : one (1) tablet,rapid dissolve, dr daily (daily). 10. fentanyl citrate 25-100 mcg iv q4h:prn 11. lorazepam 1-2 mg iv q2h:prn 12. dornase alfa 1 mg/ml solution : 2.5 ml inhalation daily (). 13. topiramate 50 mg tablet : five (5) tablet po at bedtime. 14. topiramate 50 mg tablet : 4.5 tablets po qam. discharge disposition: extended care facility: and rehab discharge diagnosis: tracheobronchomalacia with airway occlusion from granulation tissue. diptheria encephalitis, infantile spasms progressing to refractory seizure d/o s/p vagal nerve stimulator in tracheostomy/y-stent/g-tube in @ c/b pseudomonal/mrsa pna discharge condition: stable discharge instructions: follow-up with dr. precautions: contact: (mrsa; ); seizure followup instructions: follow-up with dr. as needed follow-up with dr. md procedure: continuous invasive mechanical ventilation for 96 consecutive hours or more enteral infusion of concentrated nutritional substances other intubation of respiratory tract bronchoscopy through artificial stoma bronchoscopy through artificial stoma bronchoscopy through artificial stoma revision of tracheostomy replacement of tracheostomy tube endoscopic excision or destruction of lesion or tissue of bronchus removal of intraluminal foreign body from trachea and bronchus without incision diagnoses: epilepsy, unspecified, without mention of intractable epilepsy other diseases of trachea and bronchus mechanical complication of tracheostomy other diseases of respiratory system, not elsewhere classified 

Answer: The patient is high likely exposed to